InvestorsHub Logo
Followers 536
Posts 34173
Boards Moderated 5
Alias Born 02/28/2013

Re: Peggy post# 7751

Wednesday, 03/04/2015 3:23:46 PM

Wednesday, March 04, 2015 3:23:46 PM

Post# of 9201
Verde Science plans to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs for a variety of ailments including chronic pain, inflammation, migraines, seizures related to epilepsy, nausea associated with cancer treatment, and numerous others. The company then plans to then conduct clinical trials in Canada after it obtains its Canadian R&D license